Replies to post #217261 on Biotech Values

[DewDiligence]

ATRA sells 4.93M* shares@$35.00—an 18% discount to Tuesday’s close:

https://finance.yahoo.com/news/atara-biotherapeutics-announces-pricing-public-023000547.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

ATRA +21% on EAN abstract re phase-1 ATA188 data in MS; the abstract was posted on the EAN website today at 12:30pm ET.

Commentary:
https://www.evaluate.com/vantage/articles/events/conferences/ean-2020-ataras-multiple-sclerosis-plan-slowly-takes-shape